Details for New Drug Application (NDA): 008809

✉ Email this page to a colleague

NDA 008809 describes M.V.I.-12 ADULT, which is a drug marketed by Hospira and is included in one NDA. Additional details are available on the M.V.I.-12 ADULT profile page.

The generic ingredient in M.V.I.-12 ADULT is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin; thiamine hydrochloride; vitamin a; vitamin e. There are six drug master file entries for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin; thiamine hydrochloride; vitamin a; vitamin e profile page.

Tradename:	M.V.I.-12 ADULT
Applicant:	Hospira
Ingredient:	ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin; thiamine hydrochloride; vitamin a; vitamin e
Patents:	0

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	10MG/ML;0.006MG/ML;0.5MCG/ML;1.5MG/ML;20 IU/ML;0.04MG/ML;4MG/ML;0.4MG/ML;0.36MG/ML;0.3MG/ML;330 UNITS/ML;1 IU/ML
Approval Date:	Aug 8, 1985	TE:		RLD:	No

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	20MG/ML;0.006MG/ML;0.5MCG/ML;1.5MG/ML;20 IU/ML;0.6MG/ML;4MG/ML;0.4MG/ML;0.36MG/ML;0.6MG/ML;330 UNITS/ML;1 IU/ML
Approval Date:	Apr 22, 2004	TE:		RLD:	No

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML
Approval Date:	Sep 9, 2004	TE:		RLD:	Yes

Complete Access Available with Subscription